USA-USFDACVM-2026-US-025912
Received 2026-03-21 · MSK · MSK
- Species
- Dog
- Breed
- Dog (unknown)
- Age
- 8+ years (9 Year)
- Sex
- Male Unknown
- Region
- USA
- Reactions
- NauseaIndigestion
- Body systems
- DigestiveOther
- Outcomes
- Outcome Unknown
Roxee Medication Guide
Trazodone
Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.
Both
Reference partial
Not FDA-approved for animals
Multiple FDA labelers
Official label facts
Owner quick guide first
Veterinary professional?
Showing simplified owner view. Switch to Vet View for full technical detail.
Some reference facts for this medication are still being verified.
Not FDA-approved as an animal drug.
No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.
Do not start, stop, or change treatment without your veterinarian.
Data freshness
Reference facts
Reference refreshed
Aug 6, 2026, 7:47 p.m.
Roxee has a partial reference profile for this medication. Some primary facts still need verification.
FDA applications
FDA application data refreshed
Aug 6, 2026, 7:47 p.m.
Sponsor, product, and application records imported from Animal Drugs @ FDA.
Safety reports
Safety data refreshed
Aug 6, 2026, 7:49 p.m.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
Source timing details
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Illustration placeholder
Trazodone
Trazodone
Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals
Both
81% reference complete
Species: Both
Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Trazodone
Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus. Species commonly shown: Both.
Generic name
Trazodone
Brand names
Trazodone HCl
Manufacturer
Multiple FDA labelers
Species
Both
Completeness
81%
Validation
Incomplete
Brand names
Trazodone HCl
Indications / Uses
Senvelgo (velagliflozin oral solution) is approved in cats for control of hyperglycemia associated with diabetes mellitus.
Side Effects
Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in Neurological), Decreased appetite, Death by euthanasia, Not eating.
FAQ
Both
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.accessdata.fda.gov/spl/data/c76d8407-a97b-4843-93d2-9e6c6c2ff584/c76d8407-a97b-4843-93d2-9e6c6c2ff584.xml
- Verified source: https://www.accessdata.fda.gov/spl/data/9027fb09-8b93-4107-af76-604cc5f99368/9027fb09-8b93-4107-af76-604cc5f99368.xml
- Last refreshed: Aug 6, 2026, 7:47 p.m.
- Last verified: Apr 15, 2026, 10:04 a.m.
- Validation status: Incomplete
Add to My Pet's Medications
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continuePet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Roxee still has limited plain-language guidance for this medication. Use the official documents and your veterinarian's instructions for product-specific details.
Used for:
Your vet decides this. Here's what owners typically ask/watch for.
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- Hair loss (1 reports)
- Cyst NOS (1 reports)
- Cyanotic mucous membranes (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Research brief
Medication Research Insights
A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.
What to know
Evidence-backed context
Limited
Roxee has limited cited overview evidence for Trazodone; use the official documents and your veterinarian's instructions for product-specific decisions.
Source: openFDA case USA-USFDACVM-2026-US-011403
Safety signal coverage
Reported signals
32 tracked reaction signals; 32 reported cases; 26 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.
Source: openFDA case USA-USFDACVM-2026-US-011403
Interpretation guardrail
Not causation
Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.
Evidence tension
Stronger signal
Label / review
Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.
Source: openFDA case USA-USFDACVM-2026-US-011403
Weaker signal
Reported data
Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.
Reaction signal map
Most reported reactions
Top terms
Hair loss (1 reports), Cyst NOS (1 reports), Cyanotic mucous membranes (1 reports), Crust (1 reports), Convulsion (1 reports)
Body systems represented
Signal grouping
Digestive (1), Skin & allergy (2), Neurologic (3), Behavior (2)
Species and breed lens
Species represented in reports
Species lens
Dog (28 reports), Cat (4 reports)
Breed metadata in reports
Metadata only
Crossbred Canine/dog (2), Dachshund - Miniature (1), Dog (unknown) (1), Retriever - Labrador (1). These are report metadata, not proof that a breed is at higher risk.
What your vet may verify
Fit for this patient
Vet check
Verify whether Trazodone fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.
Evidence limitations
Evidence review
Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.
What to watch next
Watch list
Owner-safe
Hair loss, Cyst NOS, Cyanotic mucous membranes
Call sooner if
Escalation
Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.
Bottom line: Use this Trazodone brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.
Vet source depth
- openFDA case USA-USFDACVM-2026-US-011403 · adverse_reaction · adverse reactions
- Structured Product Label · document · documents
- Structured Product Label · document · documents
Evidence
Review status / Updated / Sources
Review status: Clinical reviewer not listed
Updated: April 15, 2026, 10:04 AM UTC
Sources:
- openFDA case USA-USFDACVM-2026-US-011403 · adverse_reaction
- Structured Product Label · document
- Structured Product Label · document
Safety & side effects
Side effects to monitor:
- Hair loss
- Cyst NOS
- Cyanotic mucous membranes
Most reported reactions:
- Hair loss (1 reports)
- Cyst NOS (1 reports)
- Cyanotic mucous membranes (1 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Vet Fast Scan
Source-backed clinical checkpoints for quick review.
FDA-labeled species
Not linked yet
Indication / use
Your vet decides this. Here's what owners typically ask/watch for.
Form / route / dose
Confirm product label and patient-specific plan.
Warnings
No structured warnings linked yet.
Adverse-event caveat
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Source docs
- Trazodone HCl SPL SPL
- Trazodone HCl SPL SPL
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Species: Both
Manufacturer: Multiple FDA labelers
Identifiers:
NDC Package: 73309-317-01
NDC Package: 73309-317-02
NDC Package: 73377-170-01
NDC Package: 73377-170-02
NDC Product: 73309
NDC Product: 73377
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Reported case explorer
Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.
openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.
Stored reports
21
Matching reports
19
Active filters
1
Selected filters
Body system: Other
Clear
Drill into common report signals
Showing up to 50 matching reports.
USA-USFDACVM-2026-US-012895
Received 2026-03-19 · MSK · MSK
- Species
- Dog
- Breed
- Shepherd Dog - German
- Size / weight
- 50-99 lb (30.844 Kilogram)
- Age
- 4-7 years (4 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Injection site painInjection site swellingEmesis (multiple)Decreased appetitePica NOSLocalised pain NOS (see other SOCs for specific pain)Eosinophilia
- Body systems
- OtherSkin & allergyDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-014559
Received 2026-03-17 · MSK · MSK
- Species
- Dog
- Breed
- Crossbred Canine/dog
- Size / weight
- 50-99 lb (37.648 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- RegurgitationMalaiseWobblinessBalance problemWeaknessConfusionCircling - neurological disorder (see also Behavioural disorders)VomitingDecreased appetiteDecreased bowel movementsLeukocytosis NOSNeutrophiliaMonocytosisEosinopeniaHypoproteinaemiaReduced globulinsElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)
- Body systems
- OtherNeurologicDigestive
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-013265
Received 2026-03-16 · MSK · MSK
- Species
- Dog
- Breed
- Corso Dog
- Size / weight
- 50-99 lb (42.184 Kilogram)
- Age
- 1-3 years (1 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)Not eatingFeverInjection site lumpApplication site serous discharge
- Body systems
- NeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-013584
Received 2026-03-13 · MSK · MSK
- Species
- Dog
- Breed
- Crossbred Canine/dog
- Size / weight
- 25-49 lb (15.876 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- ItchingLicking
- Body systems
- Skin & allergyOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-013526
Received 2026-03-13 · MSK · MSK
- Species
- Dog
- Breed
- ['Beagle', 'Dog (unknown)']
- Size / weight
- 25-49 lb (22.044 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Lack of efficacy (endoparasite) - roundworm NOSLack of efficacy (endoparasite) - hookwormExcessive appetiteAnal and rectal disorder NOS
- Body systems
- EffectivenessDigestiveOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-011403
Received 2026-03-11 · MSK · MSK
- Species
- Dog
- Breed
- ['Shepherd Dog (unspecified)', 'Dog (unknown)']
- Size / weight
- 50-99 lb (25.62 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- DehiscenceIntestinal perforationPleural effusionPeritonitisDeath by euthanasiaPeriodontal disorderOral cavity disorder NOSSurgical site disorderAbdominal discomfortAbnormal radiograph finding
- Body systems
- Other
- Outcomes
- Euthanized
USA-USFDACVM-2026-US-011382
Received 2026-03-10 · MSK · MSK
- Species
- Dog
- Breed
- Dog (unknown)
- Size / weight
- 25-49 lb (15.286 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Lack of efficacy - NOSIntentional misuse
- Body systems
- EffectivenessOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-007819
Received 2026-02-19 · MSK · MSK
- Species
- Dog
- Breed
- Shepherd (unspecified)
- Size / weight
- 50-99 lb (28.576 Kilogram)
- Age
- 4-7 years (4 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Bloody diarrhoeaVomitingDehydrationIncreased packed cell volume (PCV)DiarrhoeaWeight loss
- Body systems
- DigestiveOther
- Outcomes
- Ongoing
USA-USFDACVM-2026-US-004595
Received 2026-01-26 · MSK · MSK
- Species
- Dog
- Breed
- Bulldog - American
- Age
- 4-7 years (5.16 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Other abnormal test result NOSTooth disorderBumps on skinCyst NOSAllergy NOSLoose stoolCrustLocal erythemaLickingDermal noduleOtitis NOSScratchingSneezingDermatitisBehavioural disorder NOSHair loss NOSNasal dischargeWeight gainSkin disorders NOSAlopecia generalAbnormal cytologyLocalised pain NOS (see other SOCs for specific pain)Salivary stainingAnxietySkin lumpMast cell tumourReddening of the skinSkin lesion NOSLack of efficacy (bacteria) - Ehrlichia
- Body systems
- OtherBehaviorSkin & allergyDigestiveEffectiveness
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-075395
Received 2025-12-23 · MSK · MSK
- Species
- Dog
- Breed
- ['Retriever (unspecified)', 'Dog (unknown)']
- Size / weight
- 50-99 lb (30.754 Kilogram)
- Age
- 8+ years (12 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Not eatingWobblinessLethargy (see also Central nervous system depression in Neurological)
- Body systems
- OtherNeurologic
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-074457
Received 2025-12-19 · MSK · MSK
- Species
- Dog
- Breed
- ['Beagle', 'Dog (unknown)']
- Size / weight
- 25-49 lb (14.061 Kilogram)
- Age
- 1-3 years (3.5 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)AgitationSeizure NOSElevated symmetrical dimethylarginine (SDMA)FallingStiffness NOSConfusionShivering
- Body systems
- NeurologicOther
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-074384
Received 2025-12-18 · MSK · MSK
- Species
- Dog
- Breed
- Shepherd Dog - German
- Size / weight
- 50-99 lb (38.555 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Limb weaknessHind limb ataxiaProprioception deficitDifficulty standingHind limb paresisLoose stoolNot himself/herselfElevated serum alkaline phosphatase (ALP)Elevated creatinineColitisSpondylosisAbnormal radiograph finding
- Body systems
- OtherNeurologic
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-074439
Received 2025-12-09 · MSK · MSK
- Species
- Dog
- Breed
- ['Retriever - Golden', 'Poodle - Standard']
- Size / weight
- 100+ lb (46 Kilogram)
- Age
- 8+ years (8 Year)
- Sex
- Male Intact
- Region
- USA
- Reactions
- Seizure NOSRough recovery
- Body systems
- NeurologicOther
- Outcomes
- Recovered/Normal
USA-USFDACVM-2025-US-072887
Received 2025-12-05 · MSK · MSK
- Species
- Dog
- Breed
- Retriever - Labrador
- Size / weight
- 50-99 lb (34.428 Kilogram)
- Age
- 8+ years (13 Year)
- Sex
- Female Unknown
- Region
- USA
- Reactions
- Lethargy (see also Central nervous system depression in Neurological)Unable to standWeakness
- Body systems
- NeurologicOther
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-072217
Received 2025-11-26 · MSK · MSK
- Species
- Dog
- Breed
- Pug
- Size / weight
- 10-24 lb (9.979 Kilogram)
- Age
- 4-7 years (7 Year)
- Sex
- Male Intact
- Region
- USA
- Reactions
- Deafness
- Body systems
- Other
- Outcomes
- Outcome Unknown
USA-USFDACVM-2025-US-070411
Received 2025-11-25 · MSK · MSK
- Species
- Dog
- Breed
- Dog (unknown)
- Size / weight
- 25-49 lb (19.3 Kilogram)
- Age
- 8+ years (11 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Musculoskeletal disorder NOSWalking difficulty
- Body systems
- Other
- Outcomes
- Ongoing
USA-USFDACVM-2025-US-069345
Received 2025-11-19 · MSK · MSK
- Species
- Dog
- Breed
- Boxer (German Boxer)
- Size / weight
- 50-99 lb (30.844 Kilogram)
- Age
- 8+ years (1 Year)
- Sex
- Female Neutered
- Region
- USA
- Reactions
- Collapse NOS (see also Cardio-vascular and Neurological disorders)BradycardiaPaddlingLateral recumbencyReduced responsesAbnormal menace reflex test
- Body systems
- NeurologicOther
- Outcomes
- Recovered/Normal
USA-USFDACVM-2025-US-069108
Received 2025-11-19 · MSK · MSK
- Species
- Cat
- Breed
- Cat (other)
- Size / weight
- 10-24 lb (5.352 Kilogram)
- Age
- 8+ years (9 Year)
- Sex
- Male Neutered
- Region
- USA
- Reactions
- Skin lesion NOSFacial pruritusAlopecia
- Body systems
- OtherSkin & allergy
- Outcomes
- Ongoing
Tap or hover a reaction to see what it means in plain language.
Tracked signals
32
Reported cases
32
Serious reports
26
Species represented
2
Grouped by Body System
Digestive (1)
· Bloody diarrhoea
Skin & allergy (2)
· Hair loss, Alopecia general
Neurologic (3)
· Unsteady walking (ataxia), Convulsion, Circling - neurological disorder
Behavior (2)
· Behavioral disorder (unspecified), Anxiety
Other (24)
· Cyst NOS, Cyanotic mucous membranes, Crust
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Skin & allergy | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Neurologic | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (28) Cat (4)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Neurologic | Cat | Non-serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Neurologic | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Neurologic | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Behavior | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Behavior | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Skin & allergy | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 |
Source metadata:
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2026-US-011403
Source Documents
The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.
Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.
Full source previews and metadata remain in the veterinary/professional layer.
Owner handouts
0No owner handouts linked yet.
Official label / PI
0No official label or package insert links yet.
SPL
2FOI
0No FOI links yet.
Trazodone HCl SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Trazodone HCl. Use the source link for the full official labeling record.
Trazodone HCl SPL
SPL · Structured Product Label
FDA Structured Product Label XML for Trazodone HCl. Use the source link for the full official labeling record.
Source metadata:
- https://www.accessdata.fda.gov/spl/data/9027fb09-8b93-4107-af76-604cc5f99368/9027fb09-8b93-4107-af76-604cc5f99368.xml · document · Structured Product Label
- https://www.accessdata.fda.gov/spl/data/c76d8407-a97b-4843-93d2-9e6c6c2ff584/c76d8407-a97b-4843-93d2-9e6c6c2ff584.xml · document · Structured Product Label
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
Data freshness
-
Reference facts:
Source Roxee
| Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
Official (FDA)
Identity: Generic ingredient
• FDA branded products available
Official FDA brands:
Trazodone HCl
Manufacturer mapping:
Multiple FDA labelers
Case-reported brands (openFDA):
MSK
Catalog species: Both
NDC:
Packages
73309-317-01
73309-317-02
73377-170-01
73377-170-02
•
Products
73309
73377
Diagnosis Codes
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
Top reaction signals
Hair loss (1)
Cyst NOS (1)
Cyanotic mucous membranes (1)
Crust (1)
Convulsion (1)
Confusion (1)
Coma (1)
Collapse NOS (1)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
Identifiers
NDC Package: 73309-317-01
NDC Package: 73309-317-02
NDC Package: 73377-170-01
NDC Package: 73377-170-02
NDC Product: 73309
NDC Product: 73377
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 73309-317-01 | 73309 | - | |
| 73309-317-02 | 73309 | - | |
| 73377-170-01 | 73377 | - | |
| 73377-170-02 | 73377 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
Trazodone HCl SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
-
Trazodone HCl SPL
• Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
Official 115
Clinical 7
Manufacturer 0
Marketing 0
Current Field Facts
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Lethargy (see also Central nervous system depression in Neurological), Decreased appetite, Death by euth… (Clinical, 2026-04-11)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-06)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-05)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-04)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-03)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-02)
- manufacturer_name: Multiple FDA labelers (Official, 2026-08-01)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-31)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-30)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-29)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-28)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-27)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-26)
- manufacturer_name: Multiple FDA labelers (Official, 2026-07-25)
Recent Revisions
- side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-13 10:06 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-12 17:56 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-11 19:04 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-11 08:49 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-11 08:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-10 21:24 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-07 10:06 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-06 20:16 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-06 08:13 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-03 20:16 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-03 11:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-02 22:45 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-07-01 23:29 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|
Data source: FDA Animal Drugs @ FDA (public search export).
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Digestive
Bloody diarrhoea (1)
• Dog
Showing top 5 for Digestive.
Skin & allergy
Hair loss (1)
• Cat
Alopecia general (1)
• Dog
Showing top 5 for Skin & allergy.
Neurologic
Unsteady walking (1)
• Cat
Convulsion (1)
• Dog
Circling - neurological disorder (1)
• Dog
Showing top 5 for Neurologic.
Behavior
Behavioral disorder (1)
• Dog
Anxiety (1)
• Dog
Showing top 5 for Behavior.
Other
Cyst NOS (1)
• Dog
Cyanotic mucous membranes (1)
• Dog
Crust (1)
• Dog
Constricted pupils (1)
• Cat
Confusion (1)
• Dog
Show more (19)
Coma (1)
• Dog
Collapse NOS (1)
• Dog
Colitis (1)
• Dog
Cellulitis (1)
• Dog
Cardiorespiratory arrest (1)
• Dog
Bumps on skin (1)
• Dog
Bradycardia (1)
• Dog
Balance problem (1)
• Dog
Asystole (1)
• Dog
Aspiration pneumonia (1)
• Cat
Application site serous discharge (1)
• Dog
Anal and rectal disorder NOS (1)
• Dog
Anaemia NOS (1)
• Dog
Allergy NOS (1)
• Dog
Agitation (1)
• Dog
Abnormal radiograph finding (1)
• Dog
Abnormal menace reflex test (1)
• Dog
Abnormal cytology (1)
• Dog
Abdominal discomfort (1)
• Dog
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Dachshund - Miniature, Male, 9 month, 3.2 kilogram • Drug: MSK, Oral • Reactions: Vomiting • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2026-US-014631
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 9.00 Month
- Weight: 3.200 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
Reactions Reported:
Vomiting
Outcomes: Recovered/Normal
Dog, Dog (unknown), Male, 9 year • Drug: MSK, Tablet, Oral, Dose: 50 Milligram per animal • Reactions: Nausea, Indigestion • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2026-US-025912
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 9.00 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 50 Milligram per animal
Reactions Reported:
Nausea
Indigestion
Outcomes: Outcome Unknown
Dog, Retriever - Labrador, Female, 8 year, 42.8 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy - NOS • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2026-US-013334
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 8.00 Year
- Weight: 42.800 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Lack of efficacy - NOS
Outcomes: Outcome Unknown
Dog, Shepherd Dog - German, Female, 4 year, 30.844 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Injection site pain, Injection site swelling, Vomiting, Decreased appetite, Pica NOS… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-012895
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 4.00 Year
- Weight: 30.844 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Unassigned
Reactions Reported:
Injection site pain
Injection site swelling
Vomiting
Decreased appetite
Pica NOS
Localised pain NOS
Eosinophilia
Outcomes: Ongoing
Dog, Crossbred Canine/dog, Male, 7 year, 37.648 kilogram • Drug: MSK, Tablet, Oral • Reactions: Regurgitation, Malaise, Wobbliness, Balance problem, Weakness… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-014559
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 7.00 Year
- Weight: 37.648 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
Reactions Reported:
Regurgitation
Malaise
Wobbliness
Balance problem
Weakness
Confusion
Circling - neurological disorder
Vomiting
Decreased appetite
Decreased bowel movements
Leukocytosis NOS
Neutrophilia
Monocytosis
Eosinopenia
Hypoproteinaemia
Reduced globulins
Elevated alanine aminotransferase
Elevated serum alkaline phosphatase
Outcomes: Ongoing
Dog, Corso Dog, Female, 1 year, 42.184 kilogram • Drug: MSK, Unknown • Reactions: Tiredness (lethargy), Not eating, Fever, Injection site lump, Application site serous discharge • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-013265
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 1.00 Year
- Weight: 42.184 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Tiredness (lethargy)
Not eating
Fever
Injection site lump
Application site serous discharge
Outcomes: Ongoing
Dog, Crossbred Canine/dog, Female, 10 year, 15.876 kilogram • Drug: MSK, Unknown • Reactions: Itching, Licking • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-013584
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 10.00 Year
- Weight: 15.876 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Itching
Licking
Outcomes: Ongoing
Dog, ['Beagle', 'Dog (unknown)'], Female, 8 year, 22.044 kilogram • Drug: MSK, Unknown • Reactions: Lack of efficacy (endoparasite) - roundworm NOS, Lack of efficacy (endoparasite) - hookworm, Excessive appetite, Anal and rectal disorder NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2026-US-013526
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 8.00 Year
- Weight: 22.044 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Reactions Reported:
Lack of efficacy (endoparasite) - roundworm NOS
Lack of efficacy (endoparasite) - hookworm
Excessive appetite
Anal and rectal disorder NOS
Outcomes: Ongoing
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
No community reviews yet. Be the first to share your experience.
This medication has not been reviewed by a veterinarian yet.
Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.